Hong Kong-listed Vitasoy International Holdings Limited reported that it repurchased 6,000 ordinary shares on 13 October 2026 at HKD 6.775 each, spending HKD 0.04 million. The transaction, executed on the Stock Exchange of Hong Kong, did not alter the company’s issued share capital, which remains at 1.02 billion shares.

Since the current mandate became effective on 24 August 2026, Vitasoy has bought back 5.47 million shares for cancellation at a volume-weighted average cost of approximately HKD 6.47 per share, equivalent to an aggregate outlay of about HKD 35.41 million. The cumulative repurchases represent 0.54% of the company’s issued shares as at the mandate date.

Pricing details show the buy-backs were executed within a tight range of HKD 6.32 to HKD 6.80 per share over the period from 25 August to 13 October 2026. The latest purchase price of HKD 6.775 sits near the upper end of that range.

Under the shareholder mandate approved on 24 August 2026, Vitasoy is authorised to repurchase up to 101.76 million shares. After accounting for the 5.47 million shares already acquired, approximately 96.28 million shares—about 9.46% of issued share capital—remain available for further buy-backs.

All repurchased shares are intended for cancellation, and no treasury shares are being retained. The company is subject to a moratorium on new share issues or sales of treasury shares until 12 November 2026, in accordance with Hong Kong Stock Exchange rules.